Citation 102161

HOULT,JRS: PAYA,M:. (1996). PHARMACOLOGICAL AND BIOCHEMICAL ACTIONS OF SIMPLE COUMARINS: NATURAL PRODUCTS WITH THERAPEUTIC POTENTIAL.. 27(4)

Citation Details

Title	PHARMACOLOGICAL AND BIOCHEMICAL ACTIONS OF SIMPLE COUMARINS: NATURAL PRODUCTS WITH THERAPEUTIC POTENTIAL.
Authors	HOULT,JRS: PAYA,M:
Year	1996
Volume	27
Issue	4

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	COUMARIN	ACTIVE
2	ANTIEDEMA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN HUMANS	COUMARIN	ACTIVE
3	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN HUMANS	COUMARIN	ACTIVE
4	METABOLISM OF	PHARMACOLOGY OF COMPOUND - IN HUMANS	COUMARIN	ACTIVE
5	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	COUMARIN	ACTIVE
6	INTERLEUKIN-2 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPARONE	ACTIVE
7	INTERLEUKIN RECEPTOR EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPARONE	ACTIVE
8	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPARONE	ACTIVE
9	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPARONE	ACTIVE
10	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPARONE	ACTIVE
11	HYPOTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OSTHOL	ACTIVE
12	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
13	THROMBOXANE B-2 SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
14	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
15	SPASMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
16	LEUKOTRIENE B-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FRAXETIN	WEAK ACTIVITY
17	THROMBOXANE B-2 SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FRAXETIN	INACTIVE
18	ANTIISCHEMIC EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FRAXETIN	ACTIVE
19	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FRAXETIN	ACTIVE
20	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FRAXETIN	ACTIVE
21	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FRAXETIN	WEAK ACTIVITY
22	LEUKOTRIENE B-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAPHNETIN,4-METHYL:	INACTIVE
23	THROMBOXANE B-2 SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAPHNETIN,4-METHYL:	INACTIVE
24	ANTIISCHEMIC EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNETIN,4-METHYL:	ACTIVE
25	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAPHNETIN,4-METHYL:	ACTIVE
26	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAPHNETIN,4-METHYL:	ACTIVE
27	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAPHNETIN,4-METHYL:	WEAK ACTIVITY
28	LEUKOTRIENE B-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMARIN,5-7-DIHYDROXY-4-METHYL:	INACTIVE
29	THROMBOXANE B-2 SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMARIN,5-7-DIHYDROXY-4-METHYL:	ACTIVE
30	ANTIISCHEMIC EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN,5-7-DIHYDROXY-4-METHYL:	ACTIVE
31	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMARIN,5-7-DIHYDROXY-4-METHYL:	ACTIVE
32	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMARIN,5-7-DIHYDROXY-4-METHYL:	INACTIVE
33	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMARIN,5-7-DIHYDROXY-4-METHYL:	ACTIVE

Citation 102161

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1